BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32946012)

  • 1. Treatment Patterns and Outcomes of Women with Breast Cancer and Supraclavicular Nodal Metastases.
    Tamirisa NP; Ren Y; Campbell BM; Thomas SM; Fayanju OM; Plichta JK; Rosenberger LH; Force J; Hyslop T; Hwang ES; Greenup RA
    Ann Surg Oncol; 2021 Apr; 28(4):2146-2154. PubMed ID: 32946012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of nodal involvement region in clinical stage IIIc breast cancer patients who received primary systemic treatment, surgery, and radiotherapy.
    Noh JM; Kim KH; Park W; Suh CO; Huh SJ; Choi DH; Keum KC; Kim YB
    Breast; 2015 Oct; 24(5):637-41. PubMed ID: 26283599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodal response to primary systemic therapy predicts prognosis of cN3c breast cancer patients receiving multimodality therapy.
    Li S; Qi W; Cao L; Xu C; Cai R; Chen J; Cai G
    Breast; 2023 Aug; 70():92-99. PubMed ID: 37423063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary Outcomes After Multimodality Therapy in Patients With Breast Cancer Presenting With Ipsilateral Supraclavicular Node Involvement.
    Diao K; Andring LM; Barcenas CH; Singh P; Carisa Le-Petross H; Reed VK; Reddy JP; Bloom ES; Ahmad NR; Mayo LL; Perkins GH; Mitchell MP; Nead KT; Tereffe W; Smith BD; Woodward WA
    Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):66-74. PubMed ID: 34710521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nodal Response to Neoadjuvant Chemotherapy Predicts Receipt of Radiation Therapy After Breast Cancer Diagnosis.
    Fayanju OM; Ren Y; Suneja G; Thomas SM; Greenup RA; Plichta JK; Rosenberger LH; Force J; Hyslop T; Hwang ES
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):377-389. PubMed ID: 31678225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
    Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
    Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
    Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
    Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival advantage associated with multimodal therapy in women with node-positive (stage-IIIC) uterine papillary serous carcinoma: a National Cancer Database study.
    Lin JF; Muñiz K; Sukumvanich P; Gehrig P; Beriwal S; Kelley JL; Edwards RP; Olawaiye AB
    BJOG; 2016 Oct; 123(11):1846-52. PubMed ID: 26537059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement.
    Christopherson K; Lei X; Barcenas C; Buchholz TA; Garg N; Hoffman KE; Kuerer HM; Mittendorf E; Perkins G; Shaitelman SF; Smith GL; Stauder M; Strom EA; Tereffe W; Woodward WA; Smith BD
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):574-581. PubMed ID: 30851348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer tumor histopathology, stage at presentation, and treatment in the extremes of age.
    Plichta JK; Thomas SM; Vernon R; Fayanju OM; Rosenberger LH; Hyslop T; Hwang ES; Greenup RA
    Breast Cancer Res Treat; 2020 Feb; 180(1):227-235. PubMed ID: 31980967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma.
    Tamirisa N; Williamson HV; Thomas SM; Westbrook KE; Greenup RA; Plichta JK; Rosenberger LH; Hyslop T; Hwang ES; Fayanju OM
    J Surg Oncol; 2019 Aug; 120(2):132-141. PubMed ID: 31062375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study.
    Ecker BL; McMillan MT; Datta J; Dempsey DT; Karakousis GC; Fraker DL; Drebin JA; Mamtani R; Giantonio BJ; Roses RE
    Eur J Cancer; 2016 Dec; 69():135-141. PubMed ID: 27821316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Locoregional Treatment in Vulvar Cancer With Pelvic Lymph Node Metastases: Time to Reconsider FIGO Staging?
    Shinde A; Li R; Amini A; Chen YJ; Cristea M; Wang W; Wakabyashi M; Han E; Yashar C; Albuquerque K; Beriwal S; Glaser S
    J Natl Compr Canc Netw; 2019 Aug; 17(8):922-930. PubMed ID: 31390593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.
    Jiao D; Zhang J; Zhu J; Guo X; Yang Y; Xiao H; Liu Z
    BMC Cancer; 2021 Feb; 21(1):138. PubMed ID: 33549037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of positron emission tomography-staged clinical N3 breast cancer treated with neoadjuvant chemotherapy, surgery, and radiotherapy.
    Park HJ; Shin KH; Cho KH; Park IH; Lee KS; Ro J; Jung SY; Lee S; Kim SW; Kang HS; Chie EK; Ha SW
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e689-95. PubMed ID: 21300467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke.
    Woodward WA; Giordano SH; Duan Z; Hortobagyi GN; Buchholz TA
    Cancer; 2006 Jun; 106(12):2556-62. PubMed ID: 16691617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival.
    Lang JE; Tereffe W; Mitchell MP; Rao R; Feng L; Meric-Bernstam F; Bedrosian I; Kuerer HM; Hunt KK; Hortobagyi GN; Babiera GV
    Ann Surg Oncol; 2013 Jun; 20(6):1893-9. PubMed ID: 23306905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of surgery for early-stage invasive breast cancer on breast cancer-specific survival, overall survival, and recurrence risk: a population-based analysis.
    Thöne K; Rudolph A; Obi N; Chang-Claude J; Flesch-Janys D
    Breast Cancer Res Treat; 2018 Jul; 170(2):381-390. PubMed ID: 29556781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmastectomy Radiation Therapy Based on Pathologic Nodal Status in Clinical Node-Positive Stage II to III Breast Cancer Treated with Neoadjuvant Chemotherapy.
    Huang Z; Zhu L; Huang XB; Tang Y; Rong QL; Shi M; Wang WH; Tie J; Shen LF; Chen JY; Zhang J; Wu HF; Cheng J; Liu M; Tan YT; Ma CY; Wang SL; Li YX
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):1030-1039. PubMed ID: 32585337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast-conserving surgery with or without irradiation in women with invasive ductal carcinoma of the breast receiving preoperative systemic therapy: A cohort study.
    Zhang J; Lu CY; Qin L; Chen HM; Wu SY
    Breast; 2020 Dec; 54():139-147. PubMed ID: 33049657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.